Cell Source, Inc. Modification Agreements

7 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 2 to Veto Cell Production and Clinical Trial Program Agreement between Cell Source Limited and The University of Texas M.D. Anderson Cancer Center
Modification Agreements
Cell Source, Inc.
Biotechnology
2024
Amendment No. 3 to Veto Cell Production and Clinical Trial Program Agreement between Cell Source Limited and The University of Texas M.D. Anderson Cancer Center
Modification Agreements
Cell Source, Inc.
Biotechnology
2024
Amendment No. 2 to Sponsored Research Agreement between Cell Source Limited and The University of Texas M.D. Anderson Cancer Center
Modification Agreements
Cell Source, Inc.
Biotechnology
2022
Amendment No. 1 to Veto Cell Production and Clinical Trial Program Agreement between Cell Source Limited and The University of Texas M.D. Anderson Cancer Center
Modification Agreements
Cell Source, Inc.
Biotechnology
2019
Amendment and Waiver Agreement to Promissory Note between Cell Source, Inc. and Noteholder
Modification Agreements
Cell Source, Inc.
Biotechnology
2015
Amendment to Promissory Notes between Cell Source, Inc. and Itamar Shimrat (June 2015)
Modification Agreements
Cell Source, Inc.
Biotechnology
2015
Third Amendment to Evaluation and Exclusive Option Agreement between Yeda Research and Development Company Ltd. and Cell Source Ltd.
Modification Agreements
Cell Source, Inc.
Biotechnology
2014